Skip to main content
Quick Links
The Campaign for UWA
School of Pathology and Laboratory Medicine
Faculty Home School Home Current Students Staff
UWA Website
The Sub-site
People
UWA Expertise
Structure
Navigation Menu
UWA Home Medicine, Dentistry and Health Sciences School of Pathology and Laboratory Medicine Contact us Staff profiles
School of Pathology and Laboratory Medicine
Staff profiles
Dr Chan Yoon Cheah
Clinical Senior Lecturer
Pathology and Laboratory Medicine, School of
Contact details
Address
School of Pathology and Laboratory Medicine
The University of Western Australia (M504)
35 Stirling Highway
CRAWLEY WA 6009
Australia
Email
chan.cheah@uwa.edu.au
Biography
Dr Cheah is a Consultant Haematologist at Sir Charles Gairdner Hospital, Pathwest Laboratory Medicine WA and Hollywood Private Hospital. He received his MBBS from the University of Western Australia in 2003 and completed post-graduate training in Clinical and Laboratory Haematology in Perth (Fremantle Hospital) and Melbourne. He completed a Translational Research Fellowship at Peter MacCallum Cancer Centre (Melbourne, Australia) and an Advanced Lymphoma Fellowship at MD Anderson Cancer Center (Houston, Texas, USA).
Key research
Dr Cheah performs clinical research focused on improving outcomes for patients with lymphoma.
Publications
Over 55 peer reviewed publications and 4 book chapters. Top 10 recent publications:

El-Galaly TC, Cheah CY, Hutchings M, Mikhaeel NG, Savage KJ, Sehn LH, Barrington S, Hansen JW, Poulsen MØ, Smith D, Rady K, Mylam KJ, Larsen TS, Holmberg S, Juul MB, Cordua S, Clausen MR, Jensen KB, Bøgsted M, Johnsen HE,
Seymour JF, Connors JM, Brown PD, Villa D. Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement. Br J Haematol. 2016 Sep 29. doi: 10.1111/bjh.14325. [Epub ahead of print] PubMed PMID: 27681999.

Cheah CY, Chihara D, Horowitz S, Sevin A, Oki Y, Zhou S, Fowler NH, Romaguera JE, Turturro F, Hagemeister FB, Fayad LE, Wang M, Neelapu SS, Nastoupil LJ, Westin JR, Rodriguez MA, Samaniego F, Anderlini P, Nieto Y, Fanale MA. Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes. Ann Oncol. 2016 Jul;27(7):1317-23. doi: 10.1093/annonc/mdw169. PubMed PMID: 27091808.

Cheah CY, Chihara D, Ahmed M, Davis RE, Nastoupil LJ, Phansalkar K, Hagemeister FB, Fayad LE, Westin JR, Oki Y, Fanale MA, Romaguera JE, Wang ML, Lee H, Turturro F, Samaniego F, Rodriguez MA, Neelapu SS, Fowler NH. Factors
influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era. Ann Oncol. 2016 May;27(5):895-901. doi: 10.1093/annonc/mdw026. PubMed PMID: 26802151.

Cheah CY, Seymour JF, Wang ML. Mantle Cell Lymphoma. J Clin Oncol. 2016 Apr 10;34(11):1256-69. doi: 10.1200/JCO.2015.63.5904. Epub 2016 Jan 11. Review. PubMed PMID: 26755518.

Cheah CY, Belada D, Fanale MA, Janikova A, Czucman MS, Flinn IW, Kapp AV, Ashkenazi A, Kelley S, Bray GL, Holden S, Seymour JF. Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study. Lancet Haematol. 2015 Apr;2(4):e166-74. doi:10.1016/S2352-3026(15)00026-5. Epub 2015 Mar 25. PubMed PMID: 26687959.

Cheah CY, Nastoupil LJ, Neelapu SS, Forbes SG, Oki Y, Fowler NH. Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma. Blood. 2015 May 21;125(21):3357-9. doi:10.1182/blood-2015-03-633156. PubMed PMID: 25999447.

Cheah CY, Chihara D, Romaguera JE, Fowler NH, Seymour JF, Hagemeister FB, Champlin RE, Wang ML. Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes. Ann Oncol.
2015 Jun;26(6):1175-9. doi: 10.1093/annonc/mdv111. PubMed PMID: 25712454.

Cheah CY, Herbert KE, O'Rourke K, Kennedy GA, George A, Fedele PL, Gilbertson M, Tan SY, Ritchie DS, Opat SS, Prince HM, Dickinson M, Burbury K, Wolf M, Januszewicz EH, Tam CS, Westerman DA, Carney DA, Harrison SJ, Seymour JF. A
multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma. Br J Cancer. 2014 Sep 9;111(6):1072-9. doi: 10.1038/bjc.2014.405. Epub 2014 Jul 29. PubMed PMID: 25072255

Cheah CY, Hofman MS, Dickinson M, Wirth A, Westerman D, Harrison SJ, Burbury K, Wolf M, Januszewicz H, Herbert K, Prince HM, Carney DA, Ritchie DS, Hicks RJ, Seymour JF. Limited role for surveillance PET-CT scanning in patients with
diffuse large B-cell lymphoma in complete metabolic remission following primary therapy. Br J Cancer. 2013 Jul 23;109(2):312-7. doi: 10.1038/bjc.2013.338. Epub 2013 Jun 27. PubMed PMID: 23807169

Cheah CY, George A, Giné E, Chiappella A, Kluin-Nelemans HC, Jurczak W, Krawczyk K, Mocikova H, Klener P, Salek D, Walewski J, Szymczyk M, Smolej L, Auer RL, Ritchie DS, Arcaini L, Williams ME, Dreyling M, Seymour JF; European Mantle
Cell Lymphoma Network. Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Ann Oncol. 2013 Aug;24(8):2119-23. doi: 10.1093/annonc/mdt139. PubMed PMID: 23616279.


Roles, responsibilities and expertise
Dr Cheah is a Clinical Haematologist with subspecialty expertise is in the management of lymphoma. He provides inpatient and outpatient care to patients through the Haematology Department at Sir Charles Gairdner Hospital; as a pathologist he provides laboratory diagnostic services through Pathwest Laboratory Medicine WA.
Future research
Developing an early phase clinical trials program exploring novel agents in patients with lymphoma.
Funding received
AI, NHMRC project grant, 2013. "Phase I study of oral NMP in relapsed/refractory multiple myeloma." PI: Professor David Ritchie, Royal Melbourne Hospital.
Industrial relevance
Principal investigator on numerous industry sponsored and academic cooperative group clinical trials.
Memberships
American Society of Clinical Oncology (2012-)
American Society of Hematology (2012-)
Australasian Leukaemia and Lymphoma Group (2011-)
Haematology Society of Australia and New Zealand (2009-)
Honours and awards
Haematology Society of Australia and New Zealand New Investigator Scholarship, 2013.
Previous positions
Translational Research Fellow, Peter MacCallum Cancer Centre (Melbourne, Australia)
Lymphoma Fellow, MD Anderson Cancer Center (Houston, Texas, USA).
Teaching
UWA MD course coordinator for Haematology.
Useful links
http://orcid.org/0000-0001-7988-1565
https://www.researchgate.net/profile/Chan_Cheah270270
https://www.ncbi.nlm.nih.gov/sites/myncbi/1byEql61l4Gkw/bibliography/45222092/public/?sort=date&direction=descending
New and noteworthy
Out recently: our review of the PI3K inhibitor idelalisib in the management of patients with lymphoma just published in Blood.

www.bloodjournal.org/content/128/3/331.long?sso-checked=true
Research profile
Research profile and publications
The University of Western Australia
UWA Home
Future UWA Students
Current UWA Students
UWA Staff
Business and Industry
Alumni and Friends
Media
Give now to UWA
School of Pathology and Laboratory Medicine
Courses
Research
Postgraduate Research Opportunities
PaLM News
Community
Current Students
Staff
Contact us
University information
CRICOS Code: 00126G
Accessibility
Campus map
Contact UWA
Indigenous Commitment
Privacy and terms of use
This Page
Last updated:
Friday, 24 July, 2009 2:11 PM
Website Feedback:
brett.tizard@uwa.edu.au
http://www.pathology.uwa.edu.au/316237